Your patients with diabetes may have heard through the grapevine about resveratrol to control blood sugar. Indeed, a recent meta-analysis concluded that dietary supplements containing resveratrol significantly lowers blood glucose, A1c, and improves insulin sensitivity in patients with diabetes.1 Dietary supplements are widely available and patients spend more than 30 billion (that’s billion with a “b”) dollars on them every year. Health professionals should be prepared to... Read More
In these multimedia presentations, our moderator reviews a research manuscript and an expert panel discusses its strengths, weaknesses, and potential implications for practice.
Succinct reviews that discuss the potential impact of recently published manuscripts on ambulatory care pharmacy practice. Read the commentaries and voice your own opinions.
Featured Panel Discussion
This is a brief review of the CANTATA-SU trial and a discussion about the role of sodium glucose co-transporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
Are medications in this new class of agents something we should consider earlier in the treatment of type 2 diabetes? Or perhaps even for the treatment of type 1 diabetes? Are you concerned about their adverse effects and long-term safety? Tell us what you think by posting a comment.